Health Care
Coronavirus
Dr. Henry Miller Quoted in Reuters Vaccine Article
Title: How drugmakers can keep their pledge and still deliver an October vaccine surprise By: Michael Erman, Julie Steenhuysen, Reuters As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available ...
Henry Miller, M.S., M.D.
September 9, 2020
Blog
California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Kerry Jackson
September 9, 2020
Commentary
COVID-19 Vaccines Must Be Fully Vetted For Safety And Efficacy Before Release
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. It was hardly a ...
Henry Miller, M.S., M.D.
September 8, 2020
Commentary
Pharmaceutical Companies Ruin Prospects for COVID-19 Vaccine “October Surprise”. That’s a Good Thing.
There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. Vaccines have also assumed unprecedented political importance. The ...
Henry Miller, M.S., M.D.
September 8, 2020
Commentary
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
Sally C. Pipes
September 8, 2020
Blog
California’s Worst Bills of the Legislative Session
The final gavel fell last week on the 2020 legislative session. Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Rowena Itchon
September 8, 2020
Health Care
Wayne Winegarden – Surprise Medical Billing
If you’ve ever had a medical procedure and received a large bill from your hospital because, unknown to you, one of your doctors was not in your insurance network – that’s the subject of this podcast. PRI senior fellow Wayne Winegarden discusses his recently released study on “Surprise Medical Billing.” ...
Pacific Research Institute
September 7, 2020
Blog
Dem “Stimulus Plan” Victim of Last Night of Session Hijinks
Much has been written about perhaps the wildest last night of the legislative session ever. For those who weren’t paying attention, all but one Republican senator was quarantined when Sen. Brian Jones tested positive for COVID-19 a few days prior, forced to vote remotely. This prolonged the Senate’s work on ...
Tim Anaya
September 7, 2020
Health Care
PRI Medical Billing Study Featured in Northern California Record
Title: AB 72 brief analyzes impact of medical billing reform law that’s had bad consequences for patients and practitioners By Sarah Downey, Northern California Record A new policy brief about the impact of California AB 72 finds that the law – designed to alleviate surprise medical billing – while well-intentioned ...
Pacific Research Institute
September 3, 2020
Coronavirus
Dr. Henry Miller Explains the COVID-19 Vaccine Target Date
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to discuss the pending target deadline for a COVID-19 vaccine set by the federal government. Miller says that Americans should be concerned about the safety of a vaccine developed at such a rapid pace. Miller explains that the phase three tests ...
Henry Miller, M.S., M.D.
September 2, 2020
Dr. Henry Miller Quoted in Reuters Vaccine Article
Title: How drugmakers can keep their pledge and still deliver an October vaccine surprise By: Michael Erman, Julie Steenhuysen, Reuters As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available ...
California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
COVID-19 Vaccines Must Be Fully Vetted For Safety And Efficacy Before Release
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. It was hardly a ...
Pharmaceutical Companies Ruin Prospects for COVID-19 Vaccine “October Surprise”. That’s a Good Thing.
There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. Vaccines have also assumed unprecedented political importance. The ...
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
California’s Worst Bills of the Legislative Session
The final gavel fell last week on the 2020 legislative session. Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Wayne Winegarden – Surprise Medical Billing
If you’ve ever had a medical procedure and received a large bill from your hospital because, unknown to you, one of your doctors was not in your insurance network – that’s the subject of this podcast. PRI senior fellow Wayne Winegarden discusses his recently released study on “Surprise Medical Billing.” ...
Dem “Stimulus Plan” Victim of Last Night of Session Hijinks
Much has been written about perhaps the wildest last night of the legislative session ever. For those who weren’t paying attention, all but one Republican senator was quarantined when Sen. Brian Jones tested positive for COVID-19 a few days prior, forced to vote remotely. This prolonged the Senate’s work on ...
PRI Medical Billing Study Featured in Northern California Record
Title: AB 72 brief analyzes impact of medical billing reform law that’s had bad consequences for patients and practitioners By Sarah Downey, Northern California Record A new policy brief about the impact of California AB 72 finds that the law – designed to alleviate surprise medical billing – while well-intentioned ...
Dr. Henry Miller Explains the COVID-19 Vaccine Target Date
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to discuss the pending target deadline for a COVID-19 vaccine set by the federal government. Miller says that Americans should be concerned about the safety of a vaccine developed at such a rapid pace. Miller explains that the phase three tests ...